Trastuzumab, commonly known by its brand name Herceptin, is a targeted therapy medication primarily used in the treatment of certain types of breast cancer and gastric cancer. It is a monoclonal antibody that specifically targets the human epidermal growth factor receptor 2 (HER2), a protein that can promote the growth of cancer cells. Trastuzumab is often used in conjunction with other treatments to improve outcomes for patients with HER2-positive cancers.
Tranylcypromine is a prescription medication classified as a monoamine oxidase inhibitor (MAOI). It is primarily used to treat major depressive disorder, particularly in patients who have not responded well to other antidepressants. Tranylcypromine works by increasing the levels of certain neurotransmitters in the brain, which can help improve mood and alleviate symptoms of depression.
Tranylcypromine is approved for the treatment of:
Tranexamic acid is a medication primarily used to reduce excessive bleeding. It is classified as an antifibrinolytic agent that helps stabilize blood clots and prevent their breakdown. By reversibly binding to plasminogen and inhibiting its activation to plasmin, tranexamic acid effectively slows down the process of fibrinolysis, the body's natural mechanism for dissolving blood clots. This property makes it particularly useful in various medical situations where controlling bleeding is crucial.
Trandolapril is a medication primarily used to treat high blood pressure (hypertension) and heart failure. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. By relaxing blood vessels, Trandolapril helps to lower blood pressure, making it easier for the heart to pump blood. This medication is often prescribed alone or in combination with other antihypertensive agents to achieve optimal blood pressure control.
Trandolapril is approved for several medical uses, including:
Trametinib is a targeted therapy medication primarily used in the treatment of certain types of cancer, particularly melanoma. It belongs to a class of drugs known as MEK inhibitors, which work by blocking specific proteins involved in the growth and spread of cancer cells. Trametinib is often prescribed in combination with other cancer treatments to enhance its effectiveness.
Tralokinumab is a monoclonal antibody designed to target and inhibit interleukin13 (IL13), a cytokine involved in inflammatory processes. It is primarily used in the treatment of moderate to severe atopic dermatitis, a chronic skin condition characterized by itchy, inflamed skin. By blocking IL13, Tralokinumab helps reduce inflammation and alleviate symptoms associated with this condition.
Trabectedin, also known by its brand name Yondelis, is a chemotherapy medication primarily used to treat certain types of cancer. It is derived from the sea squirt Ecteinascidia turbinata and is classified as a marine-derived alkylating-like agent. Trabectedin is specifically indicated for the treatment of soft tissue sarcomas and ovarian cancer, particularly in patients who have already undergone other treatments. Its unique origin and mechanism of action make it a valuable option in the oncology field.
Torsemide is a loop diuretic medication primarily used to treat conditions associated with fluid retention, such as heart failure, liver disease, and kidney disorders. It helps the body eliminate excess fluid by increasing urine production. Torsemide offers consistent bioavailability and a longer duration of action compared to furosemide.
Torsemide is approved for several medical uses, including:
Toremifene is a medication primarily used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Toremifene works by interfering with the action of estrogen in the body, which can help slow or stop the growth of certain types of breast tumors that require estrogen to grow. It is FDA-approved for postmenopausal women with estrogen receptor-positive metastatic breast cancer.
Topotecan is a chemotherapy medication primarily used to treat certain types of cancer. It belongs to a class of drugs known as topoisomerase inhibitors, which work by interfering with the DNA replication process in cancer cells. By disrupting this process, Topotecan helps to slow down or stop the growth of tumors, making it an essential option in cancer treatment.
Topotecan is approved for several medical uses, including:
